The Molecular Dual artificial-intelligence platform integrates multi-omic information to expect results for pancreatic adenocarcinoma sufferers – Nature Most cancers
Affected person baseline demographics and specimen handlingOur Molecular Dual Pilot (MT-Pilot) cohort incorporated 74 sufferers at medical degree I (n = 47) and II (n = 27) with surgically resected PDAC between March 2015 and April